Full name
NOVISC PHARMA SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
46.46.Z - Wholesale of pharmaceutical goods
46.45.Z - Wholesale of perfume and cosmetics
47.73.Z - Dispensing chemist in specialised stores
47.74.Z - Retail sale of medical and orthopaedic goods in specialised stores
47.75.Z - Retail sale of cosmetic and toilet articles in specialised stores
47.91.Z - Retail sale via mail order houses or via Internet
47.99.Z - Other retail sale not in stores, stalls or markets
73.1 - Advertising
73.20.Z - Market research and public opinion polling
82.30.Z - Organisation of conventions and trade shows
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | -0,2 | -0,7 | -0 | 94,8 |
EBITDA | -0,2 | -0,6 | -0 | 93,7 |
Short time liabilities | 0,3 | 0,8 | 0,5 | -32,5 |
Equity capital | 1,5 | 0,7 | 0,7 | -4,7 |
Operating profit (EBIT) | -0,2 | -0,6 | -0 | 93,5 |
Assets | 2,5 | 2 | 1,7 | -16,5 |
Net profit (loss) | -0,2 | -0,7 | -0 | 94,8 |
Cash | 0,6 | 0 | 0 | -86,7 |
Net income from sale | 3,2 | 2,8 | 2,4 | -12,7 |
Liabilities and provisions for liabilities | 1 | 1,3 | 1 | -23,2 |
Working assets | 2,5 | 2 | 1,7 | -16,8 |
Depreciation | 0 | 0 | 0 | -∞ |
% | % | % | p.p. | |
Profitability of capital | -14,4 | -90,7 | -4,9 | 85,8 |
Equity capital to total assets | 61,4 | 36,4 | 41,6 | 5,2 |
Gross profit margin | -6,9 | -24,1 | -1,4 | 22,7 |
EBITDA Margin | -6,9 | -22,5 | -1,6 | 20,9 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 31 | 105 | 81 | -24 |
Current financial liquidity indicator | 9.340338706970215 | 2.529594898223877 | 3.116147756576538 | 0,6 |
Net dept to EBITDA | -0.6437835693359375 | -0.7022704482078552 | -11.270182609558105 | -10,6 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane